WE ARE

Sumitomo Dainippon
Pharma Oncology

Dedicated to the promise of purposeful science in oncology

Review Our Pipeline

Scientific persistence

We believe in the power of science—and our people—to make the seemingly impossible possible.

Commitment to discovery

Our external collaborations and investments aim to propel discovery in cancer treatment and complement our areas of concentration.

Our Science

We are committed to pursuing a diverse and purposeful pipeline that investigates drivers of treatment resistance and tumor progression.

Explore more

Featured Clinical Trial

Learn about our phase III clinical trial in patients with recurrent or progressive glioblastoma, featuring Ombipepimut-S Dosing Emulsion (DSP-7888), a WT1 immunotherapeutic cancer vaccine.

See our clinical trial

Join Our Team

If you have a passion for making a meaningful difference in the lives of patients and the community, we already have something in common.

Learn more